Withdrawal symptoms after long-term treatment with neuroleptics.
D000328:Adult; D000368:Aged; D001775:Blood Circulation / Q000187:drug effects; D002746:Chlorpromazine / Q000009:adverse effects; D005334:Fever / Q000209:etiology; D006801:Humans; D006948:Hyperkinesis / Q000209:etiology; D007022:Hypotension / Q000209:etiology; D007035:Hypothermia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010546:Perphenazine / Q000009:adverse effects; D011395:Promazine / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology; D013375:Substance Withdrawal Syndrome; D013546:Sweating / Q000187:drug effects; D013881:Thioridazine / Q000009:adverse effects; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014268:Trifluoperazine / Q000009:adverse effects
D014149:Tranquilizing Agents; D014268:Trifluoperazine; D010546:Perphenazine; D013881:Thioridazine; D011395:Promazine; D002746:Chlorpromazine